Dr. Perl Discusses the Impact of CAR T-Cell Therapy on ALL – OncLive
OncLive |
Dr. Perl Discusses the Impact of CAR T-Cell Therapy on ALL
OncLive Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses the impact of chimeric antigen receptor (CAR) T-cell therapy on the treatment of patients with acute lymphoblastic leukemia (ALL). Historically, there has not … |
